USPTO serial 78171952
BREAKTHROUGH SCIENCE. BREAKTHROUGH MEDICINE.
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 13, 2005
- Examiner
- SUAREZ, MARIA VICTORIA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with BREAKTHROUGH SCIENCE. BREAKTHROUGH MEDICINE.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Millennium Pharmaceuticals, Inc.
Cambridge, MA
Millennium Pharmaceuticals, Inc.
Cambridge, MA
Millennium Pharmaceuticals, Inc.
Cambridge, MA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Bevilacqua, Esquire
NANCY C DICONZA FROSS ZELNICK LEHRMAN & ZISSU PC966 UNITED NATIONS PLZNEW YORK, NY 10017UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | RESEARCH SERVICES, NAMELY, RESEARCH, DEVELOPMENT, VALIDATION, TESTING, DATA ANALYSIS AND PRODUCT DEVELOPMENT SERVICES IN THE BIOMEDICAL, GENOMIC PHARMACOGENOMIC, DIAGNOSTIC, CLINICAL TRIAL DESIGN, AND BIOTECHNOLOGY FIELDS; RESEARCH CONSULTING SERVICES, NAMELY, RESEARCH, DEVELOPMENT, VALIDATION, TESTING, DATA ANALYSIS, AND PRODUCT DEVELOPMENT SERVICES FOR OTHERS IN THE BIOMEDICAL, GENOMIC, PHARMACEUTICAL, PHARMACOGENOMICS, DIAGNOSTIC, CLINICAL TRIAL DESIGN, AND BIOTECHNOLOGY FIELDS; CONSULTATION SERVICES, NAMELY, PROVIDING CONSULTATION TO OTHERS VIA GLOBAL, NATIONAL, AND LOCAL COMPUTER NETWORKS IN THE FIELDS OF LIFE SCIENCES, PHARMACOGENOMICS, DIAGNOSTICS, CLINICAL TRIAL DESIGN AND BIOTECHNOLOGY; PROVIDING ON-LINE COMPUTER DATABASES VIA GLOBAL, NATIONAL, AND LOCAL IN THE FIELDS OF LIFE SCIENCES, PHARMACOGENOMICS, DIAGNOSTICS, CLINICAL TRIAL DESIGN AND BIOTECHNOLOGY | SECTION 8 - CANCELLED | Aug 23, 2005 |
| 044 | MEDICAL AND DIAGNOSTIC SERVICES, NAMELY, DIAGNOSING, PREVENTING, AND PREDICTING DISEASE, IDENTIFYING HEREDITARY RISK FACTORS, DIAGNOSTIC TESTING, PROGNOSTIC TESTING, GENE AND PROTEIN TESTING, IDENTIFYING PHYSIOLOGICAL CHARACTERISTICS, ESTABLISHING INDIVIDUAL PREVENTATIVE PROGRAMS, ESTABLISHING DISEASE TREATMENT BASED ON GENE AND PROTEIN EXPRESSION AND/OR ACTIVITY, EVALUATING CLINICAL TRIAL PROGRESS, DRUG MONITORING AND COMPUTER TRACKING OF A PATIENT'S HEALTH PROGRESS | SECTION 8 - CANCELLED | Aug 23, 2005 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Millennium Pharmaceuticals, Inc.
- Other trademarks owned by Millennium Pharmaceuticals, Inc.
- Other trademarks owned by Millennium Pharmaceuticals, Inc.
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BREAKTHROUGH SCIENCE. BREAKTHROUGH MEDICINE.
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2012 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 13, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 26, 2005 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Oct 21, 2005 | ALIE | ASSIGNED TO LIE | — |
| Oct 17, 2005 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 13, 2005 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 30, 2005 | PAPER RECEIVED | — | |
| Sep 27, 2005 | IUAF | USE AMENDMENT FILED | — |
| May 10, 2005 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 18, 2005 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 18, 2005 | PAPER RECEIVED | — | |
| Oct 19, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 18, 2004 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| May 21, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 9, 2004 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 6, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 17, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 13, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 27, 2003 | CFIT | CASE FILE IN TICRS | — |
| Sep 22, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 22, 2003 | PAPER RECEIVED | — | |
| Sep 17, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 17, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 14, 2003 | DOCK | ASSIGNED TO EXAMINER | — |